These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1555302)

  • 1. Role of K+ channel activators in cardiac electrophysiology and arrhythmias.
    Antzelevitch C; Di Diego JM
    Circulation; 1992 Apr; 85(4):1627-9. PubMed ID: 1555302
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
    Carlsson L; Abrahamsson C; Drews L; Duker G
    Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators.
    Fish FA; Prakash C; Roden DM
    Circulation; 1990 Oct; 82(4):1362-9. PubMed ID: 1698129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both mitochondrial KATP channel opening and sarcolemmal KATP channel blockage confer protection against ischemia/reperfusion-induced arrhythmia in anesthetized male rats.
    Gonca E; Bozdogan O
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):403-11. PubMed ID: 20693159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channel openers are likely to be proarrhythmic in the diseased human heart.
    Black SC; Lucchesi BR
    Cardiovasc Res; 1994 Jun; 28(6):923-4; discussion 926-9. PubMed ID: 7923300
    [No Abstract]   [Full Text] [Related]  

  • 6. Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry?
    Di Diego JM; Antzelevitch C
    Circulation; 1993 Sep; 88(3):1177-89. PubMed ID: 7689041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Electrophysiology of cardiac arrhythmias].
    Sumbera J; Bravený P
    Cesk Fysiol; 1977; 26(6):505-39. PubMed ID: 342125
    [No Abstract]   [Full Text] [Related]  

  • 8. An examination of the cardiac actions of PD117,302, a κ-opioid receptor agonist.
    Pugsley MK; Saint DA; Hayes ES; Abraham S; Walker MJ
    Eur J Pharmacol; 2015 Aug; 761():330-40. PubMed ID: 26086860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of spiral wave reentry by K(+) channel blockade.
    Honjo H; Yamazaki M; Kamiya K; Kodama I
    Circ J; 2007; 71 Suppl A():A26-31. PubMed ID: 17587736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental models of reentry, antiarrhythmic, and proarrhythmic actions of drugs. Complexities galore!
    el-Sherif N
    Circulation; 1991 Oct; 84(4):1871-5. PubMed ID: 1914122
    [No Abstract]   [Full Text] [Related]  

  • 11. [Potassium channels and arrhythmia].
    Funck-Brentano C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():9-13. PubMed ID: 1307198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac potassium channel subtypes: new roles in repolarization and arrhythmia.
    Schmitt N; Grunnet M; Olesen SP
    Physiol Rev; 2014 Apr; 94(2):609-53. PubMed ID: 24692356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium channels in cardiac arrhythmias: focus on antiarrhythmic drug action.
    Rials SJ; Friehling TD; Marinchak RA; Kowey PR
    Prog Clin Biol Res; 1990; 334():111-21. PubMed ID: 2408066
    [No Abstract]   [Full Text] [Related]  

  • 15. Flecainide-induced prolongation of ventricular repolarization contributes to the proarrhythmic profile of action.
    Osadchii OE
    Int J Cardiol; 2015 Oct; 197():81-2. PubMed ID: 26142191
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum Toxin-Chitosan Nanoparticles Prevent Arrhythmia in Experimental Rat Models.
    Sergeevichev D; Fomenko V; Strelnikov A; Dokuchaeva A; Vasilieva M; Chepeleva E; Rusakova Y; Artemenko S; Romanov A; Salakhutdinov N; Chernyavskiy A
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32748868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology and therapy of arrhythmias: recent findings and open problems].
    Franchi F
    Clin Ter; 1983 Jan; 104(2):95-130. PubMed ID: 6345049
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of Proarrhythmic Effects of Potassium Channel Blockers.
    Skibsbye L; Ravens U
    Card Electrophysiol Clin; 2016 Jun; 8(2):395-410. PubMed ID: 27261830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic changes in heart failure: focus on pacemaker channels.
    Sartiani L; Stillitano F; Cerbai E; Mugelli A
    Can J Physiol Pharmacol; 2009 Feb; 87(2):84-90. PubMed ID: 19234571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.